Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
US7358261B2 · kind B2 · utility
13Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 2004 |
| Grant date | Apr 15, 2008 |
| Priority date | — |
| Expiry date | Mar 27, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.